Alnylam Pharmaceuticals, Inc. (ALNY) — Business segments and KPIs
Revenue by business segment and geography for Alnylam Pharmaceuticals, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| GIVLAARI | 308.49M | 64.1% |
| ONPATTRO | 172.79M | 35.9% |
| Revenue by region | ||
| UNITED STATES | 1.73B | 74.8% |
| Europe | 405.9M | 17.5% |
| Non-US Or Europe | 176.72M | 7.6% |